Serum markers for predicting advanced fibrosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease

To compare the diagnostic utility of serum markers in nonalcoholic fatty liver disease (NAFLD) patients with chronic hepatitis B (CHB). This study enrolled 118 consecutive biopsy-proven NAFLD patients with or without CHB. Fibrosis scores of each marker were compared against histological fibrosis sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qi, Xie, Wen, Liu, Ligai, Wang, Peng, Pan, Calvin Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104229/
https://www.ncbi.nlm.nih.gov/pubmed/33950921
http://dx.doi.org/10.1097/MD.0000000000025327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104229/
https://www.ncbi.nlm.nih.gov/pubmed/33950921
http://dx.doi.org/10.1097/MD.0000000000025327

Ejemplares similares